289 related articles for article (PubMed ID: 35062793)
1. The Potential of Exosomes in Allergy Immunotherapy.
Engeroff P; Vogel M
Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062793
[TBL] [Abstract][Full Text] [Related]
2. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (ÖGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD).
Pfaar O; Bachert C; Bufe A; Buhl R; Ebner C; Eng P; Friedrichs F; Fuchs T; Hamelmann E; Hartwig-Bade D; Hering T; Huttegger I; Jung K; Klimek L; Kopp MV; Merk H; Rabe U; Saloga J; Schmid-Grendelmeier P; Schuster A; Schwerk N; Sitter H; Umpfenbach U; Wedi B; Wöhrl S; Worm M; Kleine-Tebbe J; Kaul S; Schwalfenberg A
Allergo J Int; 2014; 23(8):282-319. PubMed ID: 26120539
[TBL] [Abstract][Full Text] [Related]
3. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
Schülke S
Front Immunol; 2018; 9():455. PubMed ID: 29616018
[TBL] [Abstract][Full Text] [Related]
4. Functions of Exosomes and Microbial Extracellular Vesicles in Allergy and Contact and Delayed-Type Hypersensitivity.
Nazimek K; Bryniarski K; Askenase PW
Int Arch Allergy Immunol; 2016; 171(1):1-26. PubMed ID: 27820941
[TBL] [Abstract][Full Text] [Related]
5. The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine.
Weinberger EE; Isakovic A; Scheiblhofer S; Ramsauer C; Reiter K; Hauser-Kronberger C; Thalhamer J; Weiss R
Vaccine; 2013 Dec; 31(51):6113-21. PubMed ID: 23954383
[TBL] [Abstract][Full Text] [Related]
6. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy.
Kanagaratham C; El Ansari YS; Lewis OL; Oettgen HC
Front Immunol; 2020; 11():603050. PubMed ID: 33362785
[TBL] [Abstract][Full Text] [Related]
7. CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance.
Montamat G; Leonard C; Poli A; Klimek L; Ollert M
Front Immunol; 2021; 12():590054. PubMed ID: 33708195
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
9. Allergen-Specific Antibodies Regulate Secondary Allergen-Specific Immune Responses.
Eckl-Dorna J; Villazala-Merino S; Linhart B; Karaulov AV; Zhernov Y; Khaitov M; Niederberger-Leppin V; Valenta R
Front Immunol; 2018; 9():3131. PubMed ID: 30705676
[TBL] [Abstract][Full Text] [Related]
10. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction.
Prado N; Marazuela EG; Segura E; Fernández-García H; Villalba M; Théry C; Rodríguez R; Batanero E
J Immunol; 2008 Jul; 181(2):1519-25. PubMed ID: 18606707
[TBL] [Abstract][Full Text] [Related]
11. Recent progress in allergen immunotherapy.
Nouri-Aria KT
Iran J Immunol; 2008 Mar; 5(1):1-24. PubMed ID: 18319521
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens.
Akdis M; Akdis CA
J Allergy Clin Immunol; 2014 Mar; 133(3):621-31. PubMed ID: 24581429
[TBL] [Abstract][Full Text] [Related]
13. Exosomes - nanovesicles with possible roles in allergic inflammation.
Admyre C; Telemo E; Almqvist N; Lötvall J; Lahesmaa R; Scheynius A; Gabrielsson S
Allergy; 2008 Apr; 63(4):404-8. PubMed ID: 18315728
[TBL] [Abstract][Full Text] [Related]
14. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.
Burton OT; Tamayo JM; Stranks AJ; Koleoglou KJ; Oettgen HC
J Allergy Clin Immunol; 2018 Jan; 141(1):189-201.e3. PubMed ID: 28479335
[TBL] [Abstract][Full Text] [Related]
15. FcεRI Signaling in the Modulation of Allergic Response: Role of Mast Cell-Derived Exosomes.
Lecce M; Molfetta R; Milito ND; Santoni A; Paolini R
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751734
[TBL] [Abstract][Full Text] [Related]
16. Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?
Tulaeva I; Kratzer B; Campana R; Curin M; van Hage M; Karsonova A; Riabova K; Karaulov A; Khaitov M; Pickl WF; Valenta R
Front Immunol; 2020; 11():1368. PubMed ID: 32733455
[TBL] [Abstract][Full Text] [Related]
17. Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
Vizzardelli C; Gindl M; Roos S; Möbs C; Nagl B; Zimmann F; Sexl V; Kenner L; Neunkirchner A; Zlabinger GJ; Pickl WF; Pfützner W; Bohle B
Allergy; 2018 Apr; 73(4):851-861. PubMed ID: 29159964
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
[TBL] [Abstract][Full Text] [Related]
19. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
[TBL] [Abstract][Full Text] [Related]
20. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
